儿童非复杂性急性阑尾炎保守治疗路径与阑尾切除术的临床与成本效果比较:英国CONTRACT 2随机对照多中心开放标签平行组非劣效性试验研究方案
CONTRACT 2是一项在英国开展的多中心开放标签随机对照非劣效性试验,计划纳入376例4-15岁非复杂性急性阑尾炎患儿,按1:1随机分配至保守治疗路径(抗生素、镇痛及定期临床评估)或阑尾切除术,主要终点为随机化后1年治疗成功的复合结局,采用20%非劣效界值,并评估临床与成本效果。
要点
- 研究对象为4-15岁非复杂性急性阑尾炎患儿,排除穿孔、阑尾包块或既往保守治疗者。
- 计划样本量376例,按1:1随机分配至保守治疗路径或阑尾切除术。
- 主要终点为随机化后1年治疗成功的复合结局,非劣效界值为20%。
核心结论
- 该随机对照试验旨在确定英国非复杂性急性阑尾炎患儿中保守治疗路径相比阑尾切除术的临床与成本效果。
研究设计与样本
- 非劣效性随机对照试验,含内部预试验、卫生经济学评价和定性沟通子研究。
- 研究在英国英格兰、北爱尔兰、苏格兰和威尔士的专科儿童医院及地区综合医院开展。
- 计划纳入376例4-15岁(含)诊断为非复杂性急性阑尾炎且通常需行阑尾切除术的患儿,按1:1分配至保守治疗路径(干预组)或阑尾切除术(对照组)。
- 随机化按年龄、性别、症状持续时间和中心进行最小化。
- 主要终点为随机化后1年治疗成功的复合结局,采用20%非劣效界值进行分析。
主要发现
- 研究方案阶段,未报告主要结局结果。
关键数值与推荐
- 非劣效界值为20%,用于检验保守治疗路径非劣于阑尾切除术的假设。
- 干预组接受抗生素、镇痛和定期临床评估以确保临床改善。
- 对照组接受阑尾切除术。
- 次要结局包括住院时长、急性阑尾炎恢复指标、并发症、进一步治疗需求、持续症状、医疗资源使用、生活质量和费用。
- 不良事件、严重不良事件和可疑非预期严重不良事件通过数据库和纸质表格收集至12个月访视。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Currently, the most frequently used treatment for acute appendicitis in children in the United Kingdom (UK) is an appendicectomy. However, there is increasing scientific and patient interest and research into non-operative treatment of appendicitis. Despite a number of non-randomised studies in children and randomised studies in adults, comparative outcomes of non-operative treatment and appendicectomy in comparable groups of children remain unknown. Following the successful completion of a feasibility study, we now aim to perform a UK-based multi-centre open-label randomised controlled trial (RCT) to investigate the clinical and cost-effectiveness of non-operative treatment pathway of acute uncomplicated appendicitis in children compared with appendicectomy. METHODS: Non-inferiority RCT with internal pilot, health economic evaluation and qualitative communication sub-study. The study is conducted in England, Northern Ireland, Scotland and Wales at both specialist children's hospitals and district general hospitals. Children (aged 4-15 years inclusive) diagnosed with acute uncomplicated appendicitis that would normally be treated with an appendicectomy are eligible for the RCT. Exclusion criteria include clinical/radiological suspicion of perforated appendicitis, appendix mass or previous non-operative treatment of appendicitis. Sample size is 376 participants, recruited by surgeons and supported by research staff and randomised with a 1:1 allocation ratio to either non-operative treatment pathway (intervention) or appendicectomy (control). Participants in the intervention arm are treated with antibiotics, analgesia and regular clinical assessment to ensure clinical improvement. Participants in the control arm receive appendicectomy. Randomisation is minimised by age, sex, duration of symptoms and centre. The primary end-point is a composite outcome of treatment success at 1 year following randomisation. Secondary outcomes include: duration of hospital stay, measures of recovery from acute appendicitis, complications, need for further treatment, persistent symptoms, health care resource use, quality of life and costs. Adverse events, serious adverse events and suspected unexpected serious adverse events are collected directly on the database and by paper form up to 12-month visit. Primary outcome will be analysed on a non-inferiority basis using a 20% non-inferiority margin to test the hypothesis that non-operative treatment pathway is non-inferior to appendicectomy. Children and families who are approached for the RCT will be invited to participate in the embedded qualitative sub-study. This will include recording of recruitment consultations, which will inform future interventions to optimise recruitment. We have involved children, young people and parents in study design and delivery. DISCUSSION: This RCT will allow determination of the comparative clinical and cost-effectiveness of non-operative treatment pathway compared to appendicectomy for children with uncomplicated acute appendicitis in the UK. TRIAL STATUS: First planned enrolment-December 2022, first actual recruit-March 2022, current status of trial-open to recruitment. TRIAL REGISTRATION: ISRCTN16720026 . Registered on July 28, 2021.
引用
- Permyakova NV, Reading IC, Bridget Y, et al. The clinical and cost effectiveness of a conservative treatment pathway compared to appendicectomy in children with uncomplicated acute appendicitis: study protocol for a randomised controlled multi-centre open-label parallel-group non-inferiority trial (CONTRACT 2 trial) in the United Kingdom (UK). Trials. 2025. PMID: 41345705. doi:10.1186/s13063-025-09282-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。